Morgan Stanley Upgrades ResMed (RMD) to Overweight
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $198.43 --0%
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 5
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 9 | New: 5
Join SI Premium – FREE
Morgan Stanley upgraded ResMed (NYSE: RMD) from Equalweight to Overweight.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $56.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Upgrades Replimune Group (REPL) to Outperform
- Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
- Goldman Sachs Upgrades Tradeweb Markets (TW) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
